A role for vessel‐associated extracellular matrix proteins in multiple sclerosis pathology
Brain Pathology · 2024-11 · 34 (6)
DOI: 10.1111/bpa.13263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Pathology, online erschienen am 25.04.2024. Verfasst von Marco Pisa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Multiple Sclerosis, Extracellular Matrix Proteins, Decorin, Spinal Cord. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health Research (NIHR), Oxford Biomedical Research Centre (BRC), Oxford-Quinnipiac-Trinity Health Of New England partnership, Clarendon Fund.
Abstract (Originalsprache)
Multiple sclerosis (MS) is unsurpassed for its clinical and pathological hetherogeneity, but the biological determinants of this variability are unknown. HLA‐DRB1*15 , the main genetic risk factor for MS, influences the severity and distribution of MS pathology. This study set out to unravel the molecular determinants of the heterogeneity of MS pathology in relation to HLA‐DRB1*15 status. Shotgun proteomics from a discovery cohort of MS spinal cord samples segregated by HLA‐DRB*15 status revealed overexpression of the extracellular matrix (ECM) proteins, biglycan, decorin, and prolargin in HLA‐DRB*15 ‐positive cases, adding to established literature on a role of ECM proteins in MS pathology that has heretofore lacked systematic pathological validation. These findings informed a neuropathological characterisation of these proteins in a large autopsy cohort of 41 MS cases (18 HLA‐DRB1*15 ‐positive and 23 HLA‐DRB1*15 ‐negative), and seven non‐neurological controls on motor cortical, cervical and lumbar spinal cord tissue. Biglycan and decorin demonstrate a striking perivascular expression pattern in controls that is reduced in MS (−36.5%, p = 0.036 and − 24.7%, p = 0.039; respectively) in lesional and non‐lesional areas. A concomitant increase in diffuse parenchymal accumulation of biglycan and decorin is seen in MS ( p = 0.015 and p = 0.001, respectively), particularly in HLA‐DRB1*15 ‐positive cases ( p = 0.007 and p = 0.046, respectively). Prolargin shows a faint parenchymal pattern in controls that is markedly increased in MS cases where a perivascular deposition pattern is observed (motor cortex +97.5%, p = 0.001; cervical cord +49.1%, p = 0.016). Our findings point to ECM proteins and the vascular interface playing a central role in MS pathology within and outside the plaque area. As ECM proteins are known potent pro‐inflammatory molecules, their parenchymal accumulation may contribute to disease severity. This study brings to light novel factors that may contribute to the heterogeneity of the topographical variation of MS pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
- Oxford Medical School, University of Oxford, Oxford, UK.
- Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, UK.
- Faculty of Medicine, University of Alberta, Edmonton, Alberta, Canada.
- Mandell MS Center, Trinity Health of New England, Hartford, Connecticut, USA.
- Mass Spectrometry Laboratory, Target Discovery Institute, University of Oxford, Oxford, UK.
ORCID-Profile: Marco Pisa, Richard L Yates
Förderung
- National Institute for Health Research (NIHR), Oxford Biomedical Research Centre (BRC)
- Oxford-Quinnipiac-Trinity Health Of New England partnership
- Clarendon Fund
- Merck Serono Grant for MS Innovation
- National Institute for Health and Care Research
Zitieren
APA
Pisa, M., Watson, J. L., Spencer, J. I., Niblett, G., Mahjoub, Y., Lockhart, A., Yates, R. L., Yee, S. A., Hadley, G., Ruiz, J., Esiri, M. M., Kessler, B., Fischer, R., & DeLuca, G. C. (2024). A role for vessel‐associated extracellular matrix proteins in multiple sclerosis pathology. Brain Pathology, 34(6). https://doi.org/10.1111/bpa.13263
Vancouver
Pisa M, Watson JL, Spencer JI, Niblett G, Mahjoub Y, Lockhart A, et al. A role for vessel‐associated extracellular matrix proteins in multiple sclerosis pathology. Brain Pathology. 2024;34(6). doi:10.1111/bpa.13263
BibTeX
@article{Pisa2024,
author = {Pisa, Marco and Watson, Joseph L and Spencer, Jonathan I and Niblett, Guy and Mahjoub, Yasamin and Lockhart, Andrew and Yates, Richard L and Yee, Sydney A and Hadley, Gina and Ruiz, Jennifer and Esiri, Margaret M and Kessler, Benedict and Fischer, Roman and DeLuca, Gabriele C},
title = {A role for vessel‐associated extracellular matrix proteins in multiple sclerosis pathology},
journal = {Brain Pathology},
year = {2024},
volume = {34},
number = {6},
doi = {10.1111/bpa.13263}
}
EUVIMED